//Tag:Bioventures

Based on UAMS Research, InterveXion Wins Grants, Partners with BioVentures’ Help

Feb. 20, 2018 | Truly good ideas like the one around which InterveXion was built have staying power. Since InterveXion was established as a company in 2004, granting agencies and others have continued to value both the company and its mission. BioVentures from the first saw merit in the new treatment for methamphetamine abuse developed [...]

By | 2018-02-20T14:02:06+00:00 February 20th, 2018|Research, University News|0 Comments

Out of Research at UAMS HD Nursing Grows, Succeeds in Business

Feb. 13, 2018 | Increasing success in preventing injuries to patients in falling accidents has resulted in ever rising licensing revenue for HD Nursing, a company started with help from BioVentures at UAMS. “By the end of 2016, we were at about $250,000,” said Amy Hester, Ph.D., R.N., chief scientific officer for HD Nursing. “We [...]

By | 2018-02-23T09:07:03+00:00 February 13th, 2018|University News|0 Comments

Researchers Awarded $8 Million for Anti-Methamphetamine Medication Study

Oct. 12, 2017 | Led by UAMS researchers, a new clinical study  called STAMPOUT aims to help a drug user stay in treatment by keeping the effects of the drug from going into the brain. This month, the National Institutes of Health (NIH) National Institute on Drug Abuse awarded the InterveXion/UAMS research team an $8 [...]

By | 2017-10-12T12:30:45+00:00 October 12th, 2017|Research, University News|0 Comments

UAMS Patent Hopefuls Gather for Medical Inventions Showcase

June 14, 2017 | Potential patents for medical inventions as small as a molecule prompted big discussions among UAMS researchers who gathered for a showcase hosted June 6 by the College of Medicine to highlight medical research. “Every poster you see here today has a patent application on file with the Patent and Trademark Office,” [...]

By | 2017-06-14T11:08:33+00:00 June 14th, 2017|Faculty, Research, Student, University News|0 Comments

BioVentures Earns UAMS National Ranking of 87th Out of 225 Universities for Technology Transfer

May 12, 2017 | BioVentures recently earned the University of Arkansas for Medical Sciences (UAMS) a national ranking by the Milken Institute of 87th out of 225 universities for technology transfer — the ability to take basic research and develop it into new technologies, products and companies. UAMS ranked above several well-known institutions, including the [...]

By | 2017-05-12T14:03:49+00:00 May 12th, 2017|News Release, University News|0 Comments

UAMS, BioVentures, Conductor Extend Sign-up to May 7 for Health Sciences Entrepreneurship Boot Camp

April 27, 2017 | Arkansas college students interested in learning the fundamentals of entrepreneurship and forming new health science ventures at a residential boot camp at the University of Central Arkansas (UCA) in Conway have until May 7 to register. Held from May 22-26, the camp is a joint initiative of the University of Arkansas for [...]

By | 2017-04-27T09:01:28+00:00 April 27th, 2017|News Release|0 Comments

Arkansas Life Sciences Summit Supplies Insight, Connections for Entrepreneurs

Oct. 21, 2016 | To bring life to a state’s life sciences sector, working together is key, and the Arkansas Life Sciences Summit keynote speaker Patrick Plues could see that  spirit in abundance as he looked at his audience. About 100 entrepreneurs, investors and research scientists gathered at the summit in Conway on Oct. 19 [...]

By | 2017-01-28T09:42:26+00:00 October 21st, 2016|University News|0 Comments

InterveXion Therapeutics, a UAMS Startup, Receives $14.5 Million to Develop Drug Therapies for Methamphetamine Users

LITTLE ROCK – A University of Arkansas for Medical Sciences (UAMS) BioVentures startup company, InterveXion Therapeutics LLC, has received two federal grants totaling $14.5 million for development of drug therapies that can help methamphetamine drug abusers break their addiction.

By | 2015-08-26T09:02:59+00:00 January 29th, 2015|News Release, UAMS News|0 Comments